These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6126491)

  • 1. Hidradenitis suppurativa: evidence for a bactericidal defect correctable by cholinergic agonist in vitro and in vivo.
    Ginder PA; Ousley M; Hinthorn D; Liu C; Abdou NI
    J Clin Immunol; 1982 Jul; 2(3):237-41. PubMed ID: 6126491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malakoplakia: evidence for monocyte lysosomal abnormality correctable by cholinergic agonist in vitro and in vivo.
    Abdou NI; NaPombejara C; Sagawa A; Ragland C; Stechschulte DJ; Nilsson U; Gourley W; Watanabe I; Lindsey NJ; Allen MS
    N Engl J Med; 1977 Dec; 297(26):1413-9. PubMed ID: 200843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-defense mechanisms in hidradenitis suppurativa.
    Dvorak VC; Root RK; MacGregor RR
    Arch Dermatol; 1977 Apr; 113(4):450-3. PubMed ID: 848973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic use of cholinergic drugs acting on the vegetative nervous system. I - Direct, indirect and mixed agonists.
    Leone L; Rossini L; Lumachi B; Valsecchi B; Coppi G
    Farmaco Sci; 1981 Oct; 36(10):827-37. PubMed ID: 7030780
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholinergic dysfunction in Shy-Drager syndrome: effect of the parasympathomimetic agent, bethanechol.
    Khurana RK
    Clin Auton Res; 1994 Apr; 4(1-2):5-13. PubMed ID: 7914443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenitis suppurativa: an androgen-dependent disorder.
    Ebling FJ
    Br J Dermatol; 1986 Sep; 115(3):259-62. PubMed ID: 3756090
    [No Abstract]   [Full Text] [Related]  

  • 7. Hidradenitis suppurativa. Glucose tolerance, clinical, microbiologic, and immunologic features and HLA frequencies in 27 patients.
    O'Loughlin S; Woods R; Kirke PN; Shanahan F; Byrne A; Drury MI
    Arch Dermatol; 1988 Jul; 124(7):1043-6. PubMed ID: 3260468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilocarpine and other cholinergic drugs in the management of salivary gland dysfunction.
    Ferguson MM
    Oral Surg Oral Med Oral Pathol; 1993 Feb; 75(2):186-91. PubMed ID: 8093976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidradenitis suppurativa of the anogenital region: response to isotretinoin.
    Brown CF; Gallup DG; Brown VM
    Am J Obstet Gynecol; 1988 Jan; 158(1):12-5. PubMed ID: 3422131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptococcus milleri causing treatable infection in perineal hidradenitis suppurativa.
    Highet AS; Warren RE; Staughton RC; Roberts SO
    Br J Dermatol; 1980 Oct; 103(4):375-82. PubMed ID: 7437303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hidradenitis suppurativa involving the perineal region].
    Ben-Aharon U; Fridland M; Chatsubi I; Wechsler U
    Harefuah; 1991 Jan; 120(2):74-6. PubMed ID: 2007493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malacoplakia of the bladder: efficacy of bethanechol chloride therapy.
    Zornow DH; Landes RR; Morganstern SL; Fried FA
    J Urol; 1979 Nov; 122(5):703-4. PubMed ID: 501834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical management of severe mammary hidradenitis suppurativa.
    Moosa HH; McAuley CE; Ramasastry SS
    Ann Plast Surg; 1988 Jan; 20(1):82-5. PubMed ID: 3341719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hidradenitis suppurativa with combination hypothalamic-pituitary-ovarian and adrenal suppression. A case report.
    Camisa C; Sexton C; Friedman C
    J Reprod Med; 1989 Aug; 34(8):543-6. PubMed ID: 2509694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of isotretinoin treatment of hidradenitis suppurativa.
    Dicken CH; Powell ST; Spear KL
    J Am Acad Dermatol; 1984 Sep; 11(3):500-2. PubMed ID: 6384295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa.
    Mortimer PS; Dawber RP; Gales MA; Moore RA
    Br J Dermatol; 1986 Sep; 115(3):263-8. PubMed ID: 2944534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bactericidal defect of neutrophil function with lithium therapy.
    Friedenberg WR; Marx JJ
    Adv Exp Med Biol; 1980; 127():389-99. PubMed ID: 6250336
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycobacterium fortuitum infection: evidence of bactericidal defect due to hyperactive antigen-specific suppressor cells. Correction in vitro and in vivo by cholinergic agonist and indomethacin.
    Gardner JD; Ousley M; Godfrey W; Lindsey NJ; Abdou NI
    Am J Med; 1982 Nov; 73(5):756-64. PubMed ID: 6182796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment of suppurative axillary hidradenitis: value of a musculocutaneous island flap of the latissimus dorsi. Apropos of 3 cases].
    Blanc D; Tropet Y; Balmat P
    Ann Dermatol Venereol; 1990; 117(4):277-81. PubMed ID: 2195966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen metabolism by isolated human axillary apocrine glands in hidradenitis suppurativa.
    Barth JH; Kealey T
    Br J Dermatol; 1991 Oct; 125(4):304-8. PubMed ID: 1954117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.